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PURPOSE. To determine the riboflavin concentration in the posterior corneal stroma, Descemet’s
membrane, and endothelium prior to UV irradiation in corneal cross-linking (CXL) in humans.
METHODS. Five human deepithelialized cadaver corneas were mounted into artificial anterior
chambers. After the establishment of stable physiological hydration, two-photon imaging with
a certified multiphoton tomograph was used to determine fluorescence intensity and second
harmonic generation signals from collagen throughout each cornea by optical sectioning,
with a step size of 2.5 lm. Afterward, 0.1% riboflavin solution was applied to the anterior
corneal surface, similar to the standard CXL protocol. To determine the absolute riboflavin
concentration immediately before UV irradiation, corneas were measured by two-photon
imaging just at the end of the riboflavin imbibition and after riboflavin saturation.
RESULTS. The topical application of 0.1% riboflavin results in a riboflavin concentration that
decreases to 0.035% in the posterior stroma. Inside Descemet’s membrane and endothelium,
the concentration drops further to only approximately 0.015% at the endothelial level. Local
riboflavin distribution indicates a predominantly paracellular passive diffusion of riboflavin
into the anterior chamber.
CONCLUSION. The experimentally determined riboflavin concentration of 0.015% at the
endothelium shows a substantial discrepancy of a factor of 1.7 to the previously theoretically
calculated 0.025%. A lower riboflavin concentration at the endothelium may enable higher
radiant exposures and further improve the efficacy of CXL.
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Corneal cross-linking (CXL) is considered to be a safe andeffective procedure to halt the progression of keratectasia
such as keratoconus1,2 or post-LASIK ectasia.3 By means of UV-A
irradiation and riboflavin as the photosensitizer, reactive
oxygen species (ROS) are created, inducing new bonds in the
extracellular matrix of the cornea.4 Beside the beneficial tissue-
stiffening effect, these radicals cause damage in cellular
membranes, leading to keratocyte apoptosis.5,6 This can be
observed one month after CXL by using the optical imaging
methods confocal microscopy or optical coherence tomogra-
phy visualizing the corneal demarcation line.7,8
When ROS reach the posterior surface of the cornea,
vulnerable structures such as the endothelium may be affected
and potentially become necrotic or apoptotic. Therefore, prior
to the clinical introduction of CXL by the Dresden group, this
risk was identified, and safety thresholds were determined in
order to protect the corneal endothelium.9,10 However, these
studies used a rough estimation of the riboflavin concentration
based on theoretical calculations because no technique existed
at that time for a precise determination of the local
concentration of riboflavin.11 These considerations lead direct-
ly to the ‘‘400-lm rule’’, which demands a minimal corneal
thickness during UV irradiation.11
In the 15 years since the clinical introduction of CXL, only
few reports of endothelial damage have been published.12–17 In
addition, Mooren et al.18 could not find endothelial cell damage
even with a suprathreshold UV treatment of the human
endothelium.
The purpose of this laboratory study is to measure the
riboflavin gradient in the posterior human cornea by sectioning
based on two-photon excited riboflavin fluorescence, thus
verifying or disproving the theoretical values of the riboflavin
concentration at the endothelial level. Two-photon imaging has
the advantage of using (1) a high light-penetration depth in the
near infrared, as well as (2) the absence of out-of-focus one-photon
absorption, photobleaching, and photochemical reactions.
MATERIALS AND METHODS
Cornea Preparation for Two-Photon Fluorescence
Microscopy
Five human corneoscleral disks unsuitable for transplantation
were excised from intact globes not later than 6 hours post
mortem and evaluated for endothelial cell count (ECC) and
morphology by inverted phase-contrast microscopy (TS100
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Eclipse; Nikon, Tokyo, Japan). Subsequently, the eyes were
stored in a corneal culture medium consisting of 2% fetal
bovine serum and minimal essential medium (Sigma-Aldrich, St.
Louis, MO, USA), following the standard protocol of the eye
bank of the University Hospital of Bern. Twelve hours before
the experiments, dextran T-500 (Sigma-Aldrich Corp.) was
added at a concentration of 6% (wt/wt) to de-swell the cornea
to physiological hydration. For the experiments, corneas were
mounted into an artificial anterior chamber (Barron Precision
Instruments, Grand Blanc, MI, USA) with an IOP equivalent to
18 mm Hg and an aqueous 15% dextran T-500 solution as
aqueous humor. Afterward, remnants of epithelium were
removed using a blunt hockey knife. As previously described,19
a reservoir containing 15% dextran T-500 solution was placed
on the anterior side of the cornea to achieve stable
physiological hydration via both surfaces of the cornea. After
a stable hydration state had been reached (three identical
consecutive pachymetries, 10 minutes apart) the first two-
photon microscopy scan was performed. Afterward, the
reservoir on the anterior surface was filled with 0.1%
riboflavin-5-monophosphat in 15% dextran T-500 solution for
10 minutes (stirred each two minutes) to imitate the clinical
riboflavin imbibition. The reservoir was then removed, the
corneal surface was wiped clean without liquid, and the
second two-photon microscopy scan of the cornea was
acquired. For individual calibration, each cornea was saturated
with riboflavin by applying 0.1% riboflavin in 15% dextran
solution in the reservoir on the anterior surface of the cornea
and in the anterior chamber for 2 hours. Subsequently, a third
two-photon measurement was performed of the saturated
corneas. At each step of the experiment, the content of the
reservoirs was replaced by freshly prepared solutions. During
the entire procedure, a pressure equivalent to 18 mm Hg was
applied. Ultrasound pachymetry (SP-100; Tomey, Nagoya,
Japan) was performed after every step of the process. Dextran
T-500 in a concentration of 15% (wt/wt) was chosen as the
osmotic agent instead of the clinically used 1.1% hydroxy-
propyl methylcellulose (HPMC) because it yielded better
cellular imaging quality while keeping the same physiological
hydration.20,21 All experiments were performed at a temper-
ature of 198C.
Two-Photon Fluorescence Microscopy and
Intensity Analysis
Two-photon images were acquired using a CE-certified
multiphoton tomograph (MPTflex; JenLab GmbH, Berlin,
Germany) (Fig. 1). Sample excitation was accomplished using
a 80-MHz near-infrared Ti:Sapphire tunable laser with pulsed
widths of 100 femtoseconds. The laser beam is guided to the
system’s scan head via an articulated mirror arm (Fig. 1). Once
in the scan head, the laser beam is focused on the sample using
a 203 numerical aperture (NA) 1.0 water immersion objective
with a working distance of 1.7 mm to cover the entire corneal
thickness. Galvanometric scanners and a piezo-driven z-
scanner to change the scanning position in x, y, and z
directions are included in the system’s scan head. Second
harmonic generation (SHG) and two-photon fluorescence–
generated photons are collected by the objective, separated
based on their emission wavelength using beam splitters, and
detected simultaneously by single-photon counting using two
photomultiplier tubes (Fig. 1). Using this system, the human
cornea can be imaged with high repeatability. The mean
absolute percentage of deviation of photon counts in
consecutive measurements is 0.69% (maximum of 1.54%).
In this study, image acquisition was performed using an
excitation wavelength of 760 nm. Acquisition times were 3.2
seconds for a scanning area of 5123512 pixels, corresponding
to pixel dwell times of 0.012 milliseconds/pixel. Volumes with
400 3 400 3 200 lm3 at the interface between the posterior
cornea and anterior chamber were acquired with a 2.5-lm step
between the images. Prior to riboflavin application, laser
powers of 50 mW were used to image the tissue autofluores-
cence. Following the application of the photosensitizer, the
laser power was reduced to 27.5 mW to avoid saturation of the
signal. Laser power was kept constant throughout the entire
volume. Images were acquired with lateral and axial resolu-
tions of about 0.5 lm and 2 to 3 lm, respectively.
A first measurement was performed prior to the administra-
tion of riboflavin to gain images by two-photon excited
autofluorescence based on endogenous fluorophore NAD(P)H
and the SHG signal from collagen. The beginning of Descemet’s
membrane was determined by loss of SHG-signals in the
FIGURE 1. Two-photon imaging with a CE-certified multiphoton tomograph provides high-resolution optical sections based on riboflavin and
NAD(P)H fluorescence signals and second harmonic generation (SHG) signals from collagen. The instrumental setup inside the system’s scan head is
presented schematically.
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posterior stroma.22,23 The first image in the absence of
endothelial cells indicated the beginning of the aqueous humor,
allowing the thickness calculation of Descemet’s membrane
and corneal endothelium. As corneal thickness was maintained
constant throughout the entire course of the experiment, this
landmark was used for the determination of absolute riboflavin
concentration, which was performed as previously described.19
In brief, obtained mean gray values of each corneal depth for a
predetermined region of interest (ROI) were compared to those
of the same corneal depth in corresponding corneal stacks
(after 10 minutes of riboflavin imbibition and after riboflavin
saturation) calibrating the signal attenuation due to absorption
and scattering effects within the cornea.
Numerical Analysis
To compare absolute riboflavin concentrations between differ-
ent depths of the cornea, Mann-WhitneyU tests were performed
using statistical software (Winstat for Excel; R. Fitch, Bad
Krozingen, Germany). Significance was accepted if P < 0.05.
RESULTS
Autofluorescence and SHG Imaging Prior to the
Administration of Riboflavin
Figure 2A shows a typical SHG image of the corneal stroma
after the establishment of stable hydration, whereas Figure 2B
depicts an autofluorescence image at the endothelial level. The
fluorescence intensity is low due to the fact that the
endogenous fluorophore NAD(P)H has a low fluorescence
quantum efficiency.
Riboflavin Concentration at the Endothelial Level
The application of riboflavin resulted in a strong two-photon
fluorescence signal. The photomultiplier detecting the fluo-
rescence became saturated when using the same mean power
as in the case of a riboflavin-free cornea. Therefore, the power
was reduced to 27.5 mW.
Supplementary Figure S1 illustrates averaged riboflavin
fluorescence signals after the riboflavin imbibition and after
saturation. The ratio of gray values of the fluorescence signals
in the predetermined ROI yields the absolute riboflavin
concentration in the corresponding depth.
The average of the absolute riboflavin concentrations of all
five corneas is illustrated in Figure 3. Riboflavin concentration
decreases toward posterior, experiencing a substantial decay
within Descemet’s membrane, and reaching 0.019% 6 0.007%
at the Descemet’s membrane side of the corneal endothelium
and 0.013% 6 0.005% at the aqueous side of the endothelium,
resulting in an average concentration of 0.015% 6 0.005%
within the endothelium. Within the aqueous humor, only
minor changes of riboflavin concentrations are detected, with
an average concentration of 0.012% 6 0.004%.
When comparing the average riboflavin concentrations at
different depths, significant differences were observed (aver-
age Descemet’s membrane versus endothelium, P ¼ 0.047;
Descemet’s membrane versus aqueous humor, P ¼ 0.009).
Figure 4 depicts two-photon riboflavin fluorescence of two
representative corneas at the endothelial level after riboflavin
saturation. When analyzing the riboflavin distribution in the
endothelium, it becomes obvious that the riboflavin diffusion
pathway is predominantly paracellular. Immediately in front
and behind the endothelium the fluorescence has a homoge-
nous pattern.
FIGURE 2. A typical SHG image (A) and autofluorescence image (B) of an untreated cornea after the establishment of stable hydration.
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Endothelial Cell Density and Corneal Hydration
States During the Experiments
Average ECC was 2810 6 317 cells/mm2. Average central
corneal pachymetry at different times is listed in the Table.
DISCUSSION
The main findings of this study are that (1) the measured
riboflavin concentration of 0.015% at the endothelial level
during CXL in humans is approximately half of the theoretically
calculated concentration of 0.025% and (2) riboflavin diffusion
into the anterior chamber happens predominantly through a
passive paracellular pathway.
Before the clinical application of CXL, the Dresden group
investigated the potential impact of CXL on endothelial cells.
At that time, no precise method to measure riboflavin
concentration at the endothelial level was available. With the
assumption that riboflavin has a diffusion constant similar to
that of fluorescein, a riboflavin concentration of 0.025% was
theoretically calculated for the human endothelium prior to
CXL.9,11 In the past, the diffusion of fluorescein was
extensively studied by Araie and Maurice24 using fluoropho-
tometry. A riboflavin concentration of 0.04% was calculated for
a depth of 400 lm, and 0.025% was determined for the
endothelium level by Spoerl and Seiler.11 Apoptosis UV-A
FIGURE 3. Absolute riboflavin concentrations in the posterior cornea and aqueous humor prior to CXL. A substantial drop within Descemet’s
membrane is observed. Blue area indicates Descemet’s membrane, red area the endothelium.
FIGURE 4. Two-photon excited riboflavin fluorescence within the endothelium in two typical samples. Inside the endothelium, the intracellular
riboflavin concentration is substantially lower compared to the extracellular concentration, indicating a paracellular diffusion pathway.
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thresholds with 0.025% riboflavin were evaluated in porcine
endothelial cells in vitro,9 leading to a UV-A threshold of 0.35
mW/cm2 for a 30-minute exposure (radiant exposure 0.63 J/
cm2). For UV irradiation without riboflavin, a threshold of 4
mW/cm2 for 30-minute exposure (radiant exposure 7.2 J/cm2)
was found. This underlined the need of riboflavin not only for
the creation of ROS but also as a shielding agent to protect the
endothelium, reducing the total corneal UV-A transmission to
only 13% in humans.25 The experiments were performed in
vitro (no physiological cell arrangement) using a 100-lm-thick
cell culture layer under unlimited access to atmospheric
oxygen.
In contrast to the roughly estimated riboflavin concentration
of 0.025%, we measured experimentally an average riboflavin
concentration at the endothelium of only 0.015%. The substan-
tially smaller riboflavin concentration (0.015% vs. 0.025%), taken
together with a lower available oxygen amount in vivo, indicate
that the thresholds currently used might be too high.
A second study from the Dresden group examined in vivo
the threshold of endothelial apoptosis in rabbits and found
threshold UV doses10 similar to in vitro experiments of porcine
eyes.9 However, the translation to human eyes may not be
correct for the following reasons: (1) deepithelialized New
Zealand White rabbit corneas (weight, 2.5 kg) have a central
thickness of less than 350 lm26; (2) during a 35-minute
application of 0.1% riboflavin in 20% dextran, the cornea
shrinks to a thickness of 300 lm or less27; and (3) the
assumption of only a 12.5% UV transmission appears to be
unrealistic because other groups found a UV transmission
ranging from 9% to 13% in 600- to 800-lm-thick riboflavin-
soaked human and porcine corneas.25,28 The fact that rabbit
endothelial cells can regenerate29 may explain a possibly lower
damage threshold than that in humans. Therefore, the model
rabbit should be critically scrutinized to perform endothelial
safety experiments.
The theory of photochemical cross-linking shows that the
number of produced ROS is related to the product I3 c of UV-A
light intensity I and riboflavin concentration c.30 This means a
concentration threshold smaller by a factor of 2 may be
compensated by two-fold higher light intensity without
changing the number of induced ROS and, therefore, the
potential damage. In clinical CXL with fixed combinations of I
and c, the reduction of the threshold may be equivalent, with a
smaller minimal thickness, which means that the 400-lm rule
is falsely high. Theoretical predictions of new threshold
thickness based on the results presented here would be too
speculative because we do not have access to reliable damage
thresholds for human endothelium with riboflavin and UV
light. Therefore, such thresholds should be determined
experimentally in human cornea.
In 2016, Mooren et al.18 tried to reproduce the results of the
Dresden group using human cadaver corneoscleral disks. Using
a riboflavin concentration of 0.025% and a UV irradiance of 18
mW/cm2 for 5 minutes (radiant exposure 5.4 J/cm2) the
endothelial side was directly exposed under unlimited
atmospheric oxygen access. Endothelial microscopy 5 days
later revealed no endothelial cell damage (neither necrosis nor
apoptosis), indicating at least a 10-fold higher UV/riboflavin
oxidative damage threshold in human eyes.
In research of PubMed (search terms: CXL, complication),
six reports with 19 eyes can be found describing endothelial
damage and/or inflammation after CXL. In contrast to the
tolerated UV values found by Mooren et al.18, Hafezi et al.12
described in 2007 a case of a localized transient corneal edema
at the thinnest pachymetry after CXL in post-LASIK ectasia
using the standard Dresden protocol.The preoperative corneal
thickness including the epithelium was 400 lm. Subtracting
the epithelium by 50 lm and considering an up to 20%
shrinkage of the cornea due to the 30-minute imbibition with
riboflavin/20% dextran,31 a preirradiation thickness of approx-
imately 300 lm has to be assumed. However, 6 weeks after
CXL, the cornea cleared up again.
In 2012, Kymionis et al.13 prospectively evaluated corneal
cross-linking in thin corneas, reporting ECCs of 14 eyes with a
follow-up of 12 months. Corneal thickness after epithelial
removal was on average 373 lm (range, 340 to 399 lm).
Including a 20% shrinkage due to the riboflavin/20% dextran
imbibition process,31 a preirradiation thickness of about 300
lm is suspected. A significant reduction in ECC by290 cells/
mm2, on average, is reported, but no significant correlation
was found with preoperative corneal thickness. Only one eye
substantially lost endothelial cells (preoperative, 2708 cell/
mm2; postoperative, 1448 cells/mm2), which had an estimated
preirradiation corneal thickness of less than 300 lm.
Sharma et al.14 published a case series with persistent
corneal edema after CXL. However, no preoperative ECC was
measured, and all eyes had a preoperative (including the
epithelium) thinnest pachymetry of between 449 and 496 lm.
Subtracting the roughly 50 lm of epithelium and considering a
further shrinkage due to imbibition, a corneal thickness of 350
lm can be assumed prior to UV-A irradiation. In contrast to the
reports of Hafezi et al.12 and Kymionis et al.13, the endothelial
damage went along with severe anterior segment inflammation
accompanied by iris atrophy, pigment dispersion, or corneal
infection, making an isolated endothelial damage caused by
CXL rather questionable. Bagga et al.15 and Gokhale16 each
reported a case of persistent corneal edema after CXL. The
preoperative situation was similar to the cases of Sharma et
al.14, with the lack of preoperative ECC and pachymetry.
Gumus17 reported a case of endotheliitis after CXL, which did
not lead to a significant endothelial cell loss compared to the
fellow eye 6 months after CXL. These clinical reports
emphasize the importance of measuring the preirradiation
corneal thickness and indicate a critical preirradiation thick-
ness of 300 to 350 lm.
Another interesting issue arises from our study when
interpreting the riboflavin distribution at the endothelial
level. Obviously, riboflavin does not penetrate the endothelial
cell itself (Fig. 4) and is found mainly in the intercellular
space. As the mechanism of endothelial fluid transport has not
been fully understood in detail until today,32 this observation
might help to analyze the paracellular water flow across the
endothelium.
A limitation of the study is the use of 15% dextran as the
osmotic active dilution, although in modern CXL, dextran has
been frequently replaced by 1.1% HPMC. Another limitation
occurs due to the areal averaging of the riboflavin concertation
at the endothelial level. Locally (between the endothelial cells),
a higher concentration may exist. However, due to the flat
cylindrical shape and the tight-surface parallel arrangement of
endothelial cells, this effect might be negligible. Human
cadaver eyes might have a reduced endothelial cell metabo-
lism, which can affect cellular riboflavin uptake or transport.
In the near future, clinical in vivo two-photon imaging of the
cornea will be available as an instrument to optimize the
treatment parameters.33,34
In conclusion, the results presented here reveal a riboflavin
concentration at the endothelium substantially lower than
initially anticipated. Based on our findings, the 400-lm rule is
too high. New human endothelial UV safety thresholds need to
be evaluated in order to determine a more solid guideline for
thin corneas with a pachymetry of less than 400 lm.35 In
particular with respect to customized36 and refractive CXL,37
using substantially higher energy parameters, which are
currently entering the clinical routine.
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